Pharmacotherapy for sleep bruxism

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Macedo, Cristiane R ^a   Macedo, Elizeu C ^b   Torloni, Maria R ^a   Silva, Ademir B ^c   Prado, Gilmar F ^c  

^a Brazilian Cochrane Centre   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CLONIDINE; LEVODOPA; PLACEBO; PROPRANOLOL; TRYPTOPHAN;

DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; ELECTROMYOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; HYPOTENSION; INSOMNIA; MASSETER MUSCLE; META ANALYSIS (TOPIC); PAIN INTENSITY; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REM SLEEP; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP BRUXISM; SLEEP STAGE; SLEEP TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNCERTAINTY; XEROSTOMIA; META ANALYSIS;

AMITRIPTYLINE; BROMOCRIPTINE; CLONIDINE; HUMANS; LEVODOPA; PROPRANOLOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP BRUXISM; TRYPTOPHAN;

EID: 84944161157     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005578.pub2     Document Type: Review

References (52)

1. Etzel KR, Stockstill JW, Rugh JD, Fisher JG. Tryptophan supplementation for nocturnal bruxism: report of negative results. Journal of Craniomandibular Disorders: Facial & Oral Pain 1991;5(2):115-20.
2. Huynh N, Guitard F, Manzine C, Montplaisir JY, de Champlain J, Lavigne GJ. Lack of effect of propranolol on sleep bruxism: a controlled double-blind study. Sleep 2004;27(Abstr Suppl):A 281.
3. Huynh N, Lavigne GJ, Lanfranchi PA, Montplaisir JY, de Champlain J. The effect of 2 sympatholytic medications - propranolol and clonidine-on sleep bruxism: experimental randomized controlled studies. Sleep 2006;29(3):307-16.
4. Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clinical Neuropharmacology 2001;24(3):145-9.
5. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. Does L-dopa exacerbate sleep bruxism?. Journal of Oral Rehabilitation 1996;23(8):556-7.
6. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Movement Disorders 1997;12(1):73-8.
7. Mohamed SE, Christensen LV, Penchas J. A randomized double-blind clinical trial of the effect of amitriptyline on nocturnal masseteric motor activity (sleep bruxism). Journal of Craniomandibular Practice 1997;15(4):326-32.
8. Raigrodski AJ, Christensen LV, Mohamed SE, Gardiner DM. The effect of four-week administration of amitriptyline on sleep bruxism. A double-blind crossover clinical study. Journal of Craniomandibular Practice 2001;19(1):21-5.
9. Raigrodski AJ, Mohamed SE, Gardiner DM. The effect of amitriptyline on pain intensity and perception of stress in bruxers. Journal of Prosthodontics 2001;10(2):73-7.
10. Chasins AI. Methocarbamal (robaxin) as an adjunct in the treatment of bruxism. Journal of Dental Medicine 1959;14(3):166-70.
11. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 2008;26(2):126-35. [PUBMED: 18468272]
12. Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. American Journal of Physical Medicine & Rehabilitation 2010;89(1):16-23. [PUBMED: 19855255]
13. Lobbezoo F, Soucy JP, Hartman NG, Montplaisir JY, Lavigne GJ. Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. Journal of Dental Research 1997;79(9):1610-14.
14. Lobbezoo F, Soucy JP, Hartman NG, Montplaisir JY, Lavigne GJ. Polysomnographic and scintigraphic demonstration of the effects of the dopamine D2 receptor agonist bromocriptine on sleep bruxism. Journal of Oral Rehabilitation 1998;25(3):228.
15. Reimão R, Lefévre AB. Evaluation of flurazepam and placebo on sleep disorders in childhood. Arquivos de Neuro-psiquiatria 1982;40(1):1-13.
16. Saletu A, Parapatics S, Anderer P, Matejka M, Saletu B. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. European Archives of Psychiatry and Clinical Neuroscience 2010;260(2):163-74. [PUBMED: 19603241]
17. Saletu A, Parapatics S, Saletu B, Anderer P, Prause W, Putz H, et al.On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam. Neuropsychobiology 2005;51(4):214-25.
18. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. Journal of American Dental Association 2000;131(2):211-6.
19. Carra MC, Macaluso GM, Rompre PH, Huynh N, Parrino L, Terzano MG, et al.Clonidine has a paradoxical effect on cyclic arousal and sleep bruxism during NREM sleep. Sleep 2010;33(12):1711-6. [PUBMED: 21120152]
20. Ghanizadeh A, Zare S. A preliminary randomised double-blind placebo-controlled clinical trial of hydroxyzine for treating sleep bruxism in children. Journal of Oral Rehabilitation 2013;40(6):413-7. [PUBMED: 23550945]
21. Shim YJ, Lee MK, Kato T, Park HU, Heo K, Kim ST. Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation. Journal of Clinical Sleep Medicine 2014;10(3):291-8.
22. American Academy of Sleep Medicine. Sleep related bruxism. International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd Edition. Westchester, IL: The Academy, 2005:189-92.
23. Abe K, Shimakawa M. Genetic and developmental aspects of sleeptalking and teeth-grinding. Acta Paedopsychiatrica 1966;33(11):339-44.
24. Barder G, Lavigne G. Sleep bruxism: an overview of an oromandibular sleep movement disorder. Sleep Medicine Reviews 2000;4(1):27-43.
25. Carlsson GE, Egermark I, Magnusson T. Predictors of bruxism, other oral parafunctions, and tooth wear over a 20-year follow-up period. Journal of Orofacial Pain 2003;17(1):50-7. [PUBMED: 12756931]
26. Carra MC, Huynh N, Lavigne G. Sleep bruxism: a comprehensive overview for the dental clinician interested in sleep medicine. Dental Clinics of North America 2012;56(2):387-413. [PUBMED: 22480810]
27. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical Research Ed.) 2010;340:c332. [PUBMED: 20332509]
28. de la Hoz-Aizpurua JL, Diaz-Alonso E, LaTouche-Arbizu R, Mesa-Jimenez J. Sleep bruxism. Conceptual review and update. Medicina Oral, Patologia Oral y Cirugia Bucal 2011;16(2):e231-8. [PUBMED: 21196839]
29. Dorland . Dorland's Medical Illustrated Dictionary. 28th Edition. Philadelphia: Saunders, 1994.
30. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
31. Faulkner KBD. Bruxism: a review of the literature. Part 1. Australian Dental Journal 1990;35(3):266-76.
32. Ferini-Strambi L, Pozzi P, Manconi M, Zucconi M, Oldani A. Bruxism and nocturnal groaning. Archives Italiennes de Biologie 2011;149(4):467-77. [PUBMED: 22205592]
33. Glacos AG. Incidence of diurnal and nocturnal bruxism. Journal of Prosthetic Dentistry 1981;45(5):545-9.
34. Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
35. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
36. Kato T, Thie NM, Montplaisir JY, Lavigne GJ. Bruxism and orofacial movements during sleep. Dental Clinics of North America 2001;45(4):657-84. [PUBMED: 11699235]
37. Kato T, Monpalisir JY, Guitard F, Sessle BJ, Lund JP, Lavigne GJ. Evidence that experimentally induced sleep bruxism is a consequence of transient arousal. Journal of Dental Research 2003;82(4):284-8.
38. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17(8):739-43.
39. Lavigne GJ, Rompre PH, Montplaisir JY. Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study. Journal of Dental Research 1996;75(1):546-52.
40. Lavigne GJ, Lobbezoo F, Rompre PH, Nielsen TA, Montplaisir JY. Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep 1997;20(4):290-3.
41. Lavigne GJ, Manzine C, Kato T. Sleep bruxism. In: Kryger MH, Roth T, Dement WC editor(s). Principles and Practice of Sleep Medicine. 4th Edition. Philadelphia, PA: Saunders, 2005:946-59.
42. Lavigne GJ, Huynh N, Kato T, Okura K, Adachi K, Yao D, et al.Genesis of sleep bruxism: motor and autonomic-cardiac interactions. Archives of Oral Biology 2007;52(4):381-4. [PUBMED: 17313939]
43. Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. Journal of Oral Rehabilitation 2008;35(7):476-94. [PUBMED: 18557915]
44. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
45. Lobbezoo F, Soucy JP, Montplasir JY, Lavigne GJ. Striatal D2 receptor blinding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single photon emission computed tomography. Journal of Dental Research 1996;75(10):1804-10.
46. Lobbezoo F, Naeije M. Bruxism is mainly regulated centrally, not peripherally. Journal of Oral Rehabilitation 2001;28(12):1085-91.
47. Magee KR. Bruxism related to levodopa therapy. Journal of the American Medical Association 1970;214(1):147.
48. Melis M, Abou Atme YS. Prevalence of bruxism awareness in a Sardinian population. Cranio 2003;21(2):144-51.
49. Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest 2001;119(1):53-61.
50. Partinen M. Epidemiology sleep disorder. In: Kryger MH, Roth T, Dement W editor(s). Principles and Practice in Sleep Medicine. Philadelphia: WB Saunders, 1994:437-52.
51. Widmalm SE, Christensen RL, Gunn SM. Oral parafunction as temporomandibular disorder risk factors in children. Journal Craniomandibular Practice 1995;13(4):242-6.
52. Winocur E, Gavish A, Voikovitch M, Emodi-Perlman A, Eli I. Drugs and bruxism: a critical review. Journal of Orofacial Pain 2003;17(2):99-111. [PUBMED: 12836498]